Wall Street’s midday tape was buzzing Friday with a grab bag of winners, losers, and a few head-scratchers. From Oracle’s comedown to American Express flexing its financial muscle, here's who's making the biggest moves.
🚀 AppFolio Gets a Lift
AppFolio (APPF) jumped 7% after KeyBanc upgraded the stock to overweight with a $285 price target. Investors liked the call, and the cloud-based business software provider got a nice midday glow-up.
🛰️ AST SpaceMobile: Gravity Hits Back
After more than doubling in the past month, AST SpaceMobile (ASTS) finally hit turbulence. Shares fell 6% after Barclays double-downgraded the stock to underweight. Price target? Still $60. Translation: Wall Street thinks the space-cellular dream may be flying a little too close to the sun.
💊 Revolution Medicines Rockets Higher
Revolution Medicines (RVMD) surged 10% after the FDA granted a voucher for its cancer drug candidate daraxonrasib (RMC-6236) under the National Priority Voucher program. The treatment targets pancreatic and lung cancers—serious stuff, and investors clearly liked the regulatory nod.
💻 Core Scientific Drama
Core Scientific (CORZ) dropped more than 5% after CoreWeave called its acquisition offer "best and final," brushing off opposition from investor Two Seas Capital. Investors weren’t thrilled with the standoff.
🏦 Regional Banks Bounce (For Now)
After dragging markets lower Thursday, regional banks staged a mini-rebound. Zions (ZION) popped 4% on a Baird upgrade, Western Alliance (WAL) added 2%, and the SPDR S&P Regional Banking ETF (KRE) climbed 1%. A breather, but nobody’s calling it a comeback just yet.
📉 Oracle Gives Back Gains
Oracle (ORCL) shed 7%, giving back much of Thursday’s rally despite confirming a cloud deal with Meta. Investors seem to want more than AI buzzwords and long-term promises.
🚂 CSX Keeps Rolling
CSX (CSX) rose 3% after beating Q3 expectations with 44 cents EPS on $3.59 billion revenue. Analysts had penciled in 42 cents and $3.58 billion. Not a blowout, but enough to keep the train moving.
💳 American Express Shows Strength
American Express (AXP) jumped 6% after posting $4.14 EPS on $18.43 billion revenue, topping estimates and raising full-year guidance. Cardholders may be groaning about bills, but shareholders are smiling.
🧪 Other Movers
-
Interactive Brokers (IBKR) fell 3% despite beating earnings estimates—proof that sometimes even good news isn’t good enough.
-
Bank OZK (OZK) slipped 3% after missing Q3 earnings, extending Thursday’s sell-off.
-
Novo Nordisk (NVO) and Eli Lilly (LLY) lost 3–4% after President Trump suggested obesity drug prices could be "much lower."
-
Micron (MU) slid 2% after reports it would exit China’s server chip business.
-
Truist Financial (TFC) rose 3.5% on better-than-expected earnings.
-
Jefferies (JEF) bounced 4.2% after Oppenheimer upgraded it to outperform.
-
Intuitive Machines (LUNR) gained 3% after a Deutsche Bank upgrade.
The Bottom Line
Midday trading was a mixed bag: AppFolio and Revolution Medicines soared, Oracle and AST SpaceMobile stumbled, and regional banks tried to shake off the blues. With earnings season in full swing and politics weighing on pharma, investors are getting plenty of plot twists.